<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-130914" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Congenital Varicella Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhavsar</surname>
            <given-names>Sejal M.</given-names>
          </name>
          <aff>St George&#x02019;s University, Grenada</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mangat</surname>
            <given-names>Chetna</given-names>
          </name>
          <aff>Mayo Alix School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sejal Bhavsar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chetna Mangat declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-130914.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The varicella-zoster virus (VZV) is a highly contagious virus of the herpes family. Chickenpox (or primary VZV infection) is a common childhood disease, and now, with universal childhood varicella vaccination, most adults in the United States and Europe are immune. This activity describes the evaluation and management of congenital varicella syndrome and neonatal varicella infection and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the epidemiology of congenital varicella syndrome and neonatal varicella infection.</p></list-item><list-item><p>Review the risk factors for developing congenital varicella syndrome and neonatal varicella infection.</p></list-item><list-item><p>Outline the clinical presentations of both presentations for congenital varicella syndrome and neonatal varicella infection.</p></list-item><list-item><p>Describe how interprofessional collaboration and communication can improve outcomes for patients with congenital varicella syndrome and neonatal varicella infection.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=130914&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=130914">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-130914.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The varicella-zoster virus (VZV) is a highly contagious virus of the herpes family. Chickenpox (or primary VZV infection) is a common childhood disease. With universal childhood varicella vaccination, which was introduced in 1995, most adults in the United States (US) and Europe are immune.<xref ref-type="bibr" rid="article-130914.r1">[1]</xref> It is estimated that &#x0003e;90% of the antenatal population is seropositive for VZV IgG antibody and therefore immune to infection.<xref ref-type="bibr" rid="article-130914.r2">[2]</xref>&#x000a0;</p>
        <p>The seronegative patients are at risk of acquiring VZV during pregnancy which is associated with a higher mortality rate due to developing varicella pneumonitis. Possible&#x000a0;fetal effects of varicella&#x000a0;may also occur and include fetal demise or&#x000a0;manifestations of&#x000a0;either congenital varicella syndrome (embryopathy) or neonatal varicella (development of chickenpox or disseminated disease) the first 10 days of life), which are associated with significant morbidity and mortality.<xref ref-type="bibr" rid="article-130914.r3">[3]</xref></p>
      </sec>
      <sec id="article-130914.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The varicella-zoster virus (VZV) is a human alphaherpesvirus with worldwide distribution and is highly contagious.<xref ref-type="bibr" rid="article-130914.r4">[4]</xref> This virus is responsible for chickenpox (primary VZV infection) and herpes zoster (or shingles) infection (reactivation of latent infection). Chickenpox is acquired through contact with respiratory droplets or fluid from shingles lesions. Initially, viral replication occurs in the respiratory tract. The virus then invades local lymph nodes, leading to viremia and widespread dissemination. As the viremia increases, new cutaneous vesicular lesions erupt, with individuals typically having 250&#x000a0;to 500 lesions in varying evolution stages.&#x000a0;</p>
        <p>The incubation period for varicella is typically between 10&#x000a0;to 21 days. Individuals with primary infection may also experience a prodrome of fever, malaise, abdominal pain, and headaches. Patients with chickenpox are considered contagious from 1&#x000a0;to 2 days&#x000a0;before developing the rash until all skin lesions have crusted over. Varicella infection in pregnant women can spread via the placenta and infect the fetus.<xref ref-type="bibr" rid="article-130914.r5">[5]</xref><xref ref-type="bibr" rid="article-130914.r6">[6]</xref></p>
        <p>After chickenpox, the virus&#x000a0;becomes&#x000a0;latent in the dorsal root ganglia.&#x000a0; It can later&#x000a0;reactivate as herpes zoster (or shingles). The clinical manifestation of herpes zoster&#x000a0;includes a painful vesicular rash in a dermatomal distribution, followed by postherpetic neuralgia.&#x000a0; Direct contact with the vesicles may be contagious, especially in non-immune or immunocompromised hosts. Herpes zoster does not pose a risk to a developing fetus&#x000a0;due to circulating protective maternal antibodies transmitted through placental transfer.<xref ref-type="bibr" rid="article-130914.r7">[7]</xref><xref ref-type="bibr" rid="article-130914.r6">[6]</xref></p>
      </sec>
      <sec id="article-130914.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Varicella infection during pregnancy is uncommon due to widespread immunity in women of childbearing age after having chickenpox or varicella immunization which was introduced in 1995. Varicella infection in a seronegative pregnant female occurs&#x000a0;if she&#x000a0;acquires person-to-person transmission from direct contact with varicella-zoster lesions or respiratory droplets spread from an infected person with chickenpox. Clinical presentation and the severity of the neonate will depend on when the mother contracted the virus during the pregnancy.&#x000a0;</p>
        <p>Congenital varicella syndrome (CVS) results when a mother is infected with the&#x000a0;VZV during the first half of pregnancy. The highest risk (2%) occurs in the second trimester&#x000a0;between 13 and 20 weeks of gestation.<xref ref-type="bibr" rid="article-130914.r8">[8]</xref>&#x000a0;CVS has been reported in rare cases&#x000a0;as late as 28 weeks of gestation.<xref ref-type="bibr" rid="article-130914.r9">[9]</xref>&#x000a0;Since the first described cases in 1947, the overall number of neonates that have been reported to have congenital varicella syndrome is&#x000a0;approximately&#x000a0;41 cases per year in the US, 4 cases per year in Canada, and 7 cases per year in the United Kingdom.<xref ref-type="bibr" rid="article-130914.r9">[9]</xref><xref ref-type="bibr" rid="article-130914.r10">[10]</xref>&#x000a0;</p>
        <p>When a pregnant woman develops a varicella infection around delivery, neonatal varicella infection may occur. Mother to child transmission can occur in three ways: transplacental viremia, direct contact with skin lesions or blood during delivery, and post-natal contact by respiratory droplets or skin contact with infected vesicles.&#x000a0; Infants are at the highest risk for severe varicella infection when maternal infection develops 5 days before and 2 days after delivery. In that time period, the baby will be exposed to high viremia but will not have adequate time to acquire maternal protective antibodies.<xref ref-type="bibr" rid="article-130914.r7">[7]</xref></p>
      </sec>
      <sec id="article-130914.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Congenital Varicella Syndrome defects involve the skin, the limbs, eyes, and the central and autonomic nervous systems. Characteristic scarring skin lesions known as cicatrix occur in a dermatomal distribution throughout the body. Limb abnormalities include hypoplasia, atrophy, or malformed digits. Typical ocular defects include chorioretinitis, cataracts, and nystagmus. Central nervous system abnormalities include microcephaly, cortical atrophy, seizures, and mental retardation. Autonomic nervous system dysfunction can also occur, leading to neurogenic bladder, hydronephrosis, esophageal dilation, and gastrointestinal reflux.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref><xref ref-type="bibr" rid="article-130914.r11">[11]</xref><xref ref-type="bibr" rid="article-130914.r5">[5]</xref></p>
        <p>Infants born to mothers with varicella within the high-risk period for neonatal varicella infection are initially well appearing.&#x000a0; If they become symptomatic, they will usually present with classical vesicular skin lesions. Disseminated disease with pneumonia, hepatitis, meningoencephalitis, and severe coagulopathy resulting from liver failure and thrombocytopenia can also occur.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref></p>
      </sec>
      <sec id="article-130914.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>For congenital varicella syndrome, sampling of fetal blood or&#x000a0;amniotic fluid&#x000a0;does not reliably identify cases.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref> Prenatal ultrasounds may be used to identify severe manifestations of intrauterine VZV infection.&#x000a0;These findings include asymmetric limb shortening or malformations, intestinal and hepatic echogenic foci, intrauterine growth restriction, cerebral anomalies including hydrocephalus and microcephaly, and fetal hydrops or fetal demise.<xref ref-type="bibr" rid="article-130914.r12">[12]</xref></p>
        <p>For neonatal varicella infection, confirmation of the virus in the mother is prudent. The diagnosis of varicella in pregnant women can often be made from the classic clinical presentation of a diffuse vesicular rash in various stages of evolution. If the diagnosis is in question, the base of a vesicular skin lesion can be scraped for direct fluorescent antibody testing or PCR. Viral cultures can also be obtained but often take up to 1 week to yield results.<xref ref-type="bibr" rid="article-130914.r5">[5]</xref>&#x000a0;These diagnostic studies should also be&#x000a0;performed on suspicious lesions presenting on the infant's body.</p>
      </sec>
      <sec id="article-130914.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Since&#x000a0;the cardiovascular manifestations result from intrauterine damage to the developing fetus, antiviral therapy in the newborn period would not be expected to have much impact on the sequelae. However, if the infant develops clinical signs of active infection, acyclovir should be administered intravenously. The therapy duration is determined based on control of active VZV replication with either cessation of new skin lesion formation or with negative VZV PCR testing.&#x000a0;</p>
        <p>If a mother develops chickenpox infection during the high-risk time period for neonatal varicella infection (5 days before through 2 days after delivery), infants should receive Varicella-zoster immune globulin (VZIG) immediately after birth or as soon&#x000a0;after the maternal symptoms appear in the two days after delivery.&#x000a0; Intravenous immune globulin (IVIG) is an alternative if VZIG is unavailable. Infants should be treated even if the mother was also&#x000a0;administered&#x000a0;VZIG. These infants should be monitored carefully, and early treatment with intravenous acyclovir should be administered for breakthrough varicella infection.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref><xref ref-type="bibr" rid="article-130914.r10">[10]</xref></p>
      </sec>
      <sec id="article-130914.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other TORCH infections, including cytomegalovirus (CMV), herpes simplex virus (HSV), rubella, and toxoplasmosis, need to be considered.<xref ref-type="bibr" rid="article-130914.r13">[13]</xref> Neonates with congenital&#x000a0;CMV may present with microcephaly, periventricular calcifications, ventriculomegaly, chorioretinitis, sensorineural hearing loss, and petechiae.&#x000a0; Congenital HSV can be distinguished with a&#x000a0;vesicular rash or disseminate infection, including hepatitis and coagulopathy in a baby born to a mother with active genital HSV lesions at the time of delivery.&#x000a0; Congenital rubella syndrome presents with cataracts and congenital heart disease. Congenital toxoplasmosis can present with chorioretinitis, hydrocephalus, intracranial calcifications, and a maculopapular rash.</p>
      </sec>
      <sec id="article-130914.s9" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>The long-term side effects of VZIG and acyclovir use in the perinatal period have not been well established at this time.&#x000a0;However,&#x000a0; the benefits of mitigating severe and possibly life-threatening infections outweigh the theoretical risk.<xref ref-type="bibr" rid="article-130914.r5">[5]</xref></p>
      </sec>
      <sec id="article-130914.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The overall prognosis of infants born with congenital varicella syndrome&#x000a0;is poor, often fatal in roughly 30% of infected babies within the first month of life. Death in infancy often results from intractable gastrointestinal reflux, severe recurrent aspiration pneumonia, and respiratory failure.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref><xref ref-type="bibr" rid="article-130914.r7">[7]</xref></p>
        <p>For infants with neonatal varicella infection, if untreated, the mortality rate is as high as 31%. Death typically occurs from varicella pneumonia. The mortality rate decreases to 7% when VZIG&#x000a0;is administered.<xref ref-type="bibr" rid="article-130914.r5">[5]</xref><xref ref-type="bibr" rid="article-130914.r14">[14]</xref></p>
      </sec>
      <sec id="article-130914.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Both congenital varicella syndrome and neonatal varicella infection have a high mortality rate. Those who survive can develop infant herpes zoster (shingles) within the first or second year of life without having primary chickenpox infection.<xref ref-type="bibr" rid="article-130914.r15">[15]</xref></p>
      </sec>
      <sec id="article-130914.s12" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Obstetrician</p>
          </list-item>
          <list-item>
            <p>Neonatalogist</p>
          </list-item>
          <list-item>
            <p>Pediatrician</p>
          </list-item>
          <list-item>
            <p>Infectious disease specialist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-130914.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Maternal VZV immune status should be determined before pregnancy by reviewing the varicella infection history or vaccination documentation with two doses of the varicella vaccine. If both are negative, a VZV IgG should be obtained. Women of childbearing age without immunity should be counseled about the risks of varicella during pregnancy. Women of childbearing age who are not immune and not pregnant should receive two doses of the vaccine, given four to eight weeks apart.</p>
        <p>Because the effect on fetal development is not known, the varicella vaccine, which is a live vaccine, is contraindicated in pregnancy. Vaccination can be given in the immediate post-partum period, and breastfeeding is not a contraindication.<xref ref-type="bibr" rid="article-130914.r6">[6]</xref>&#x000a0;Prevention of VZV infection through vaccination is key to the prevention of neonatal complications.<xref ref-type="bibr" rid="article-130914.r5">[5]</xref></p>
      </sec>
      <sec id="article-130914.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management and prevention of congenital varicella syndrome involve the efforts of an interprofessional healthcare team, consisting of clinicians, mid-level practitioners, nursing staff, and pharmacists. Prevention needs to be the primary focus, and when cases occur, all healthcare team members need to contribute each from their own areas of expertise to promote better outcomes for both mother and child. [Level 5]</p>
        <p>Since vaccination is the key to preventing neonatal varicella infection complications, all clinicians should urge their patients who are not immunocompromised or pregnant to receive two doses of the varicella vaccine if they have not already had chickenpox. Clinicians should educate pregnant women who are seronegative for VZV to avoid contact with active varicella infection individuals. A team of specialists should manage pregnant women who develop chickenpox to determine treatment for them and their neonates. Pharmacists can assist with immunoglobulin therapy, and nurses will guide administration. Maternal herpes zoster, however, poses little risk of neonatal complications or CVS due to the established circulating maternal antibodies.</p>
      </sec>
      <sec id="article-130914.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=130914&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=130914">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/congenital-varicella-syndrome-congenital-chicken-pox/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=130914">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/130914/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=130914">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-130914.s16">
        <title>References</title>
        <ref id="article-130914.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelley</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Petruccelli</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Stehr-Green</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Erickson</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits.</article-title>
            <source>JAMA</source>
            <year>1991</year>
            <month>Nov</month>
            <day>20</day>
            <volume>266</volume>
            <issue>19</issue>
            <fpage>2724</fpage>
            <page-range>2724-9</page-range>
            <pub-id pub-id-type="pmid">1942425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glantz</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mushlin</surname>
                <given-names>AI</given-names>
              </name>
            </person-group>
            <article-title>Cost-effectiveness of routine antenatal varicella screening.</article-title>
            <source>Obstet Gynecol</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>519</fpage>
            <page-range>519-28</page-range>
            <pub-id pub-id-type="pmid">9540934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paryani</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Arvin</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Intrauterine infection with varicella-zoster virus after maternal varicella.</article-title>
            <source>N Engl J Med</source>
            <year>1986</year>
            <month>Jun</month>
            <day>12</day>
            <volume>314</volume>
            <issue>24</issue>
            <fpage>1542</fpage>
            <page-range>1542-6</page-range>
            <pub-id pub-id-type="pmid">3012334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ROSS</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Modification of chicken pox in family contacts by administration of gamma globulin.</article-title>
            <source>N Engl J Med</source>
            <year>1962</year>
            <month>Aug</month>
            <day>23</day>
            <volume>267</volume>
            <fpage>369</fpage>
            <page-range>369-76</page-range>
            <pub-id pub-id-type="pmid">14494142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cobelli Kett</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Perinatal varicella.</article-title>
            <source>Pediatr Rev</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-51</page-range>
            <pub-id pub-id-type="pmid">23281363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Arvin</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Varicella in the fetus and newborn.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>209</fpage>
            <page-range>209-17</page-range>
            <pub-id pub-id-type="pmid">19097954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumental</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lepage</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of varicella in neonates and infants.</article-title>
            <source>BMJ Paediatr Open</source>
            <year>2019</year>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>e000433</fpage>
            <pub-id pub-id-type="pmid">31263790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Risk of varicella infection during late pregnancy.</article-title>
            <source>Can Fam Physician</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>49</volume>
            <fpage>1445</fpage>
            <page-range>1445-6</page-range>
            <pub-id pub-id-type="pmid">14649980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Chickenpox in pregnancy: revisited.</article-title>
            <source>Reprod Toxicol</source>
            <year>2006</year>
            <month>May</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>410</fpage>
            <page-range>410-20</page-range>
            <pub-id pub-id-type="pmid">15979274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shrim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koren</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yudin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Farine</surname>
                <given-names>D</given-names>
              </name>
              <collab>MATERNAL FETAL MEDICINE COMMITTEE</collab>
            </person-group>
            <article-title>Management of varicella infection (chickenpox) in pregnancy.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>287</fpage>
            <page-range>287-292</page-range>
            <pub-id pub-id-type="pmid">22385673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ussery</surname>
                <given-names>XT</given-names>
              </name>
              <name>
                <surname>Annunziato</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gershon</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Lungu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Langston</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Congenital varicella-zoster virus infection and Barrett's esophagus.</article-title>
            <source>J Infect Dis</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>178</volume>
            <issue>2</issue>
            <fpage>539</fpage>
            <page-range>539-43</page-range>
            <pub-id pub-id-type="pmid">9697739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pretorius</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Hayward</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Stamm</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Sonographic evaluation of pregnancies with maternal varicella infection.</article-title>
            <source>J Ultrasound Med</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>459</fpage>
            <page-range>459-63</page-range>
            <pub-id pub-id-type="pmid">1337112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Pizzo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Focus on diagnosis: congenital infections (TORCH).</article-title>
            <source>Pediatr Rev</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>12</issue>
            <fpage>537</fpage>
            <page-range>537-42</page-range>
            <pub-id pub-id-type="pmid">22135424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cradock-Watson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ridehalgh</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.</article-title>
            <source>Lancet</source>
            <year>1989</year>
            <month>Aug</month>
            <day>12</day>
            <volume>2</volume>
            <issue>8659</issue>
            <fpage>371</fpage>
            <page-range>371-3</page-range>
            <pub-id pub-id-type="pmid">2569560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130914.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dworsky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Whitley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alford</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Herpes zoster in early infancy.</article-title>
            <source>Am J Dis Child</source>
            <year>1980</year>
            <month>Jun</month>
            <volume>134</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-9</page-range>
            <pub-id pub-id-type="pmid">7386437</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
